| Title: | Effects of lifelong testosterone exposure on health and disease: a Mendelian randomization study |
| Journal: | eLife |
| Published: | 16 Oct 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33063668/ |
| DOI: | https://doi.org/10.7554/elife.58914 |
| Citations: | 39 (17 in last 2 years) as of 8 Aug 2024 |
Publication 4759
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Testosterone products are prescribed to males for a variety of possible health benefits, but causal effects are unclear. Evidence from randomized trials are difficult to obtain, particularly regarding effects on long-term or rare outcomes. Mendelian randomization analyses were performed to infer phenome-wide effects of free testosterone on 461 outcomes in 161,268 males from the UK Biobank study. Lifelong increased free testosterone had beneficial effects on increased bone mineral density, and decreased body fat; adverse effects on decreased HDL, and increased risks of prostate cancer, androgenic alopecia, spinal stenosis, and hypertension; and context-dependent effects on increased hematocrit and decreased C-reactive protein. No benefit was observed for type 2 diabetes, cardiovascular or cognitive outcomes. Mendelian randomization suggests benefits of long-term increased testosterone should be considered against adverse effects, notably increased prostate cancer and hypertension. Well-powered randomized trials are needed to conclusively address risks and benefits of testosterone treatment on these outcomes.6 Authors
- Pedrum Mohammadi-Shemirani
- Michael Chong
- Marie Pigeyre
- Robert W Morton
- Hertzel C Gerstein
- Guillaume Paré
Enabling scientific discoveries that improve human health